Literature DB >> 6208955

Concordance of a point mutation 5' to the G gamma globin gene with G gamma beta +. Hereditary persistence of fetal hemoglobin in the black population.

F S Collins, C D Boehm, P G Waber, C J Stoeckert, S M Weissman, B G Forget, H H Kazazian.   

Abstract

Hereditary persistence of fetal hemoglobin (HPFH) is a genetically heterogeneous and clinically benign condition characterized by persistent expression of fetal hemoglobin (Hb F) into adulthood. In the G gamma beta + type, no major deletions in the globin gene cluster occur; adult heterozygotes produce approximately 20% Hb F, which results from overproduction of G gamma chains, with no apparent increase in production from the adjacent A gamma gene. We have recently described a point mutation 202 base pairs 5' to the cap site of the G gamma gene in an individual with G gamma beta + HPFH. This mutation abolishes a normal ApaI restriction endonuclease site, and thus can be detected by blotting of genomic DNA. We present here further data on the ApaI mutation: (1) It occurs in six of seven families with G gamma beta + HPFH. (2) In three families, detailed haplotype analysis using 11 polymorphic restriction sites in the beta globin cluster has been done. The two that carry the missing ApaI site are identical but the third, which has a normal ApaI pattern, differs from the other two in at least two sites, one of which is a new polymorphic Nco I site between the delta and beta globin genes. This suggests the possibility of a different HPFH mutation in the third family. (3) The haplotype of the G gamma beta + HPFH chromosome carrying the ApaI mutation is different from that of 108 beta A chromosomes of black individuals that have been tested. (4) The G gamma ApaI site is normal in 61 beta A and 109 beta S alleles from non-HPFH black individuals, including 22 who share the same haplotype for the intragenic G gamma, A gamma HindIII polymorphisms. These data add support to the possibility that the -202 mutation is actually causative of the G gamma beta + HPFH phenotype.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208955

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Synergistic activation of a human promoter in vivo by transcription factor Sp1.

Authors:  G M Anderson; S O Freytag
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Analysis of 5' flanking regions of the gamma globin genes from major African haplotype backgrounds associated with sickle cell disease.

Authors:  S R Month; R W Wood; P T Trifillis; P J Orchowski; B Sharon; S K Ballas; S Surrey; E Schwartz
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Point mutation associated with hereditary persistence of fetal hemoglobin decreases RNA polymerase III transcription upstream of the affected gamma-globin gene.

Authors:  D P Carlson; J Ross
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

4.  A frequent A gamma-hereditary persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with beta-thalassemia.

Authors:  S Ottolenghi; C Camaschella; P Comi; B Giglioni; M Longinotti; L Oggiano; F Dore; G Sciarratta; G Ivaldi; G Saglio
Journal:  Hum Genet       Date:  1988-05       Impact factor: 4.132

5.  The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors.

Authors:  R Mantovani; N Malgaretti; S Nicolis; A Ronchi; B Giglioni; S Ottolenghi
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

6.  A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.

Authors:  M W Rixon; R E Gelinas
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

7.  Analyses of linked beta-globin genes suggest that nondeletion forms of hereditary persistence of fetal hemoglobin are bona fide switching mutants.

Authors:  J E Metherall; F P Gillespie; B G Forget
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

8.  Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin.

Authors:  D L Gumucio; K L Rood; T A Gray; M F Riordan; C I Sartor; F S Collins
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

Review 9.  The evolution of the alpha- and beta-globin gene clusters in human populations.

Authors:  A V Hill; J S Wainscoat
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

Review 10.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.